From: Identification of potential synthetic lethal genes to p53 using a computational biology approach
Gene symbol | Drug & compound name j | Status |
---|---|---|
PLK1 | DB08059, DB07789, DB06963, DB06897, DB07186, BI 2536, cyclapolin 9, GW843682X, ADP, threonine, serine, pyridoxal, nocodazole, paclitaxel, phosphoserine, TAK-960 | experimental |
CDC7 | PHA 767491 hydrochloride, BMS-863233, NMS-1116354 | experimental |
CDK1 | flavopiridol, hymenialdisine, indirubin-3′-monoxime, olomoucine, SU9516 | experimental |
MTOR | rapamycin, everolimus | approved |
CDK16 | DB07766 | experimental |
PLK4 | ADP, microplasmin, serine, fibrinogen, cysteine | experimental |
STK17B | quercetin | experimental |
TTK | DB01782 | experimental |
STK38 | mercaptopurine | experimental |
NEK2 | DB07180 | experimental |
AURKA | Adenosine-5′-Diphosphate, phosphonothreonine, taxane, paclitaxel, serine, threonine | experimental |
BUB1 | cytosine, paclitaxel, nocodazole | experimental |
SRPK1 | gemcitabine, cisplatin, serine, arginine | experimental |
PRKCSH | VU 0155069, cellobiose | experimental |
PKC family (PRKCH, PRKCI, PRKCSH, PRKCZ) | bryostatin, aprinocarsen, enzastaurin, tamoxifen citrate, midostaurin, UCN-01 | experimental |
MARK2 | glycogen | experimental |
PDGFRA | imatinib, sorafenib, sunitinib, pazopanib, axitinib | approved |
BRD2 | PFI 1, sulfadiazine, dihydrofolate | experimental |
CHEK2 | DDUG | experimental |
CERK | NVP 231 | experimental |
UCK2 | DB03431, DB04272, DB02097, DB03403, DB02431, DB04005 | experimental |
AK2 | DB01717 | experimental |
CHKA | choline | approved |
RAF1 | sorafenib | approved |
CSNK2B | TMCB, TBB, ellagic acid | experimental |